PD-033: Cetuximab + RT shows an excellent long term OS in patients with both high ADCC and high EGFR
| Autor: | Merlano, M., Lattanzio, L., Denaro, N., Vivenza, D., Milano, G., Vigna Taglianti, R., Merlotti, A., Ferrero, M., Lo Nigro, C. |
|---|---|
| Zdroj: | In Radiotherapy and Oncology March 2017 122 Supplement 1:19-20 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect